• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Newsletters » CenterWatch Weekly

CenterWatch Weekly Sign Up Now

June 27, 2022

View Archived Issues

Download Current Issue:

  • CenterWatch Weekly, June 27, 2022

CenterWatch Holiday Notification

In observance of Independence Day in the U.S., CenterWatch Weekly will not be published Monday, July 4. The next issue will be published Monday, July 11. Read More
InclusionRed-360x240.png

Inclusion Gaps Linger for Trans and Nonbinary Populations, Special Accommodations Needed

Among the many voices involved in the ongoing discussion about increasing diversity in clinical trials, one group has received less attention from sponsors, sites and regulators alike: transgender and nonbinary people. More effort needs to go into including these populations, according to one transgender advocate, including staff site training and special accommodations. Read More
CostsBenefits-360-240.png

Decentralized Methods Gain Far More Than They Cost, New Data Show

Newly released data from a study on the costs and benefits of decentralized trials (DCT) demonstrate in hard numbers that using DCT methods can gain a sponsor or site as much as 25 times the original investment and score performance improvements in several areas. Read More

Industry Briefs

FDA Unveils Five-Year Plan for Rare Neurodegenerative Disease Research

Under a new five-year action plan for accelerating the development of treatments for rare neurodegenerative diseases, the FDA will focus on incorporating new technologies and innovative trial approaches beginning with the study of amyotrophic lateral sclerosis (ALS). Read More

Novartis Invests in Historically Black Med Schools to Advance Trial Diversity

Novartis has committed $17.7 million to establish clinical trial centers at three historically black medical schools in an effort to help increase diversity, equity and inclusion in clinical research. Read More

CBER Guidance Agenda Lists Two Trial-Related Documents Still to Come in 2022

The FDA’s Center for Biologics Evaluation and Research (CBER) has issued an updated agenda of guidances it intends to publish this year, indicating there are still two clinical research documents the center intends to address by the end of the year. Read More

Drug & Device Pipeline News

Twenty-four drugs and devices were approved or entered a new trial phase last week. Read More

Research Center Profiles

Research Center Profiles are free to use and provide comprehensive listings of hundreds of institutional and independent sites. Read More

JobWatch

JobWatch is a job posting and career development site created exclusively for clinical research professionals of all levels. Read More

Upcoming Events

  • 16Oct

    WCG MAGI's Clinical Research Conference 2022 West

  • 16Nov

    17th Annual FDA Inspections Summit

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Strategy-360x240.png

    Site Spotlight: Less Is More in Adams Clinical’s Research Strategy

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Efficient and Effective Coverage Analysis

  • InclusionRed-360x240.png

    Inclusion Gaps Linger for Trans and Nonbinary Populations, Special Accommodations Needed

  • CostsBenefits-360-240.png

    Decentralized Methods Gain Far More Than They Cost, New Data Show

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing